TRIUMPH Manuscripts

1. Decker C, Garavalia L, Garavalia B, Spertus JA. Clopidogrel-taking behavior by drug-eluting stent patients: Discontinuers versus continuers. Patient Preferences and Adherence, 2008;2:167-175.

2. Smolderen KG, Spertus JA, Reid KJ, Buchanan DM, Krumholz HM, Denollet J, Vaccarino V, Chan PS. The association of cognitive and somatic depressive symptoms with depression recognition and outcomes after myocardial infarction. Circ Cardiovasc Qual Outcomes, 2009; 2(4):328-337.

3. Garavalia L, Garavalia B, Spertus JA, Decker C. Exploring patients’ reasons for discontinuance of heart medications. J Cardiovasc Nurs, 2009, 24:(5):371-379.

4. Smolderen KG, Spertus JA, Nallamothu BK, Krumholz HM, Tang F, Ross JS, Ting HH, Alexander KP, Rathore SS, Chan PS. Health care insurance, financial concerns in accessing care, and delays to hospital presentation in acute myocardial infarction. JAMA, 2010; 303(14):1392-1400.

5. Salisbury AC, Alexander KP, Reid KJ, Masoudi FA, Rathore SS, Wang TY, Bach RG, Marso SP, Spertus JA, Kosiborod M. Incidence, correlates, and outcomes of acute, hospital-acquired anemia in patients with acute myocardial infarction. Circ Cardiovasc Qual Outcomes, 2010; 3 (4):337-346.

6. Garavalia L, Ho PM, Garavalia B, Foody JM, Kruse H, Spertus JA, Decker C. Clinician-patient discord: exploring differences in perspectives for discontinuing clopidogrel. Eur J Cardiovasc Nurs, 2011, 10(1):50-55.

7. Salisbury AC, Chan PS, Gosch KL, Buchanan DM, Spertus JA. Patterns and Predictors of Fast Food Consumption After Acute Myocardial Infarction. Am J Cardiol, 2011, 107(8):1105-1110.

8. Smolderen KG, Buchanan DM, Amin AA, Gosch K, Nugent K, Riggs L, Seavey G, Spertus JA. Real-World Lessons From the Implementation of a Depression Screening Protocol in Acute Myocardial Infarction Patients: Implications for the American Heart Association Depression Screening Advisory. 2011, Circ Cardiovasc Qual Outcomes, 2011, 4:(3):283-292.

9. Katz DA, Tang F, Faseru B, Horwitz PA, Jones P, Spertus J. Prevalence and correlates of smoking cessation pharmacotherapy in hospitalized smokers with acute myocardial infarction. Am Heart J. 2011;162(1):74-80.

10. Arnold SV, Chan PS, Jones PG, Decker C, Buchanan DM, Krumholz HM, Ho PM, Spertus JA. Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients’ Health Status (TRIUMPH): Design and Rationale of a Prospective Multicenter Registry. Circ Cardiovasc Qual Outcomes, 2011, 4:(4):467-476.

11. Garavalia L, Garavalia B, Spertus JA, Decker C. Medication Discussion Questions (MedDQ): Developing a Guide to Facilitate Patient-Clinician Communication About Heart Medications. J Cardiovasc Nur, 2011, 26:(4):E12-E19.

12. Salisbury AC, Amin AP, Harris WS, Chan PS, Gosch KL, Rich MW, O’Keefe JH, Jr., Spertus JA. Predictors of omega-3 index in patients with acute myocardial infarction. Mayo Clin Proc, 2011;86(7):626-632.

13. Wetmore JB, Gadi R, Lee JH, O’Keefe JH, Chan PS, Tang F, Spertus JA. Association of 25-hydroxyvitamin D deficiency with NT-pro BNP levels in patients with acute myocardial infarction: a cross-sectional analysis. BMC Research Notes. 2011;4(1):542.

14. Gharacholou SM, Reid KJ, Arnold SV, Spertus J, Rich MW, Pellikka PA, Singh M, Holsinger T, Krumholz HM, Peterson ED, Alexander KP. Cognitive impairment and outcomes in older adult survivors of acute myocardial infarction: Findings from the Translational Research Investigating Underlying disparities in acute Myocardial infarction Patients’ Health Status registry. Am Heart J, 2011, 162:(5):860-869 e861.

15. Morgan TM, House JA, Cresci S, Jones P, Allayee H, Hazen SL, Patel Y, Patel RS, Eapen DJ, Waddy SP, Quyyumi AA, Kleber ME, Marz W, Winkelmann BR, Boehm BO, Krumholz HM, Spertus JA. Investigation of 95 variants identified in a genome-wide study for association with mortality after acute coronary syndrome. BMC Med Genet, 2011, 12:127.

16. Cresci S, Wu J, Province MA, Spertus JA, Steffes M, McGill JB, Alderman EL, Brooks MM, Kelsey SF, Frye RL, Bach RG. Peroxisome Proliferator-Activated Receptor Pathway Gene Polymorphism Associated With Extent of Coronary Artery Disease in Patients With Type 2 Diabetes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes Trial. Circulation, 2011, 124:(13):1426-1434.

17. Lanfear DE, Jones PG, Cresci S, Tang F, Rathore SS, Spertus JA. Factors influencing patient willingness to participate in genetic research after a myocardial infarction. Genome Med, 2011, 3:(6):39.

18. Lee JH, Gadi R, Spertus JA, Tang F, O’Keefe JH. Prevalence of vitamin d deficiency in patients with acute myocardial infarction. Am J Cardiol, 2011, 107:(11):1636-1638.

19. Salisbury AC, Kosiborod M, Amin AP, Reid KJ, Alexander KP, Spertus JA, Masoudi FA. Recovery from hospital-acquired anemia after acute myocardial infarction and effect on outcomes. Am J Cardiol, 2011, 108:(7):949-954.

20. Salisbury AC, Harris WS, Amin AP, Reid KJ, O’Keefe Jr JH, Spertus JA. Relation Between Red Blood Cell Omega-3 Fatty Acid Index and Bleeding During Acute Myocardial Infarction. Am J Cardiol, 2012;109(1):13-18.

21. Smolderen KG, Spertus JA, Reid KJ, Buchanan DM, Vaccarino V, Lichtman JH, Bekelman DB, Chan PS. Association of Somatic and Cognitive Depressive Symptoms and Biomarkers in Acute Myocardial Infarction: Insights from the Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients’ Health Status Registry. Biological Psychiatry. 2012;71(1):22-29.

22. Lindau ST, Abramsohn E, Gosch K, Wroblewski K, Spatz ES, Chan PS, Spertus J, Krumholz HM. Patterns and Loss of Sexual Activity in the Year Following Hospitalization for Acute Myocardial Infarction (A United States National Multisite Observational Study). Am J Cardiol, 2012, 109:(10):1439-1444.

23. Stolker JM, Spertus JA, McGuire DK, Lind M, Tang F, Jones PG, Inzucchi SE, Rathore SS, Maddox TM, Masoudi FA, Kosiborod M. Relationship between glycosylated hemoglobin assessment and glucose therapy intensification in patients with diabetes hospitalized for acute myocardial infarction. Diabetes Care, 2012, 35:(5):991-993.

24. Bucholz EM, Rathore SS, Reid KJ, Jones PG, Chan PS, Rich MW, Spertus JA, Krumholz HM. Body Mass Index and Mortality in Acute Myocardial Infarction Patients. Am J Med, 2012, 125:(8):796-803.

25. Dodson JA, Arnold SV, Reid KJ, Gill TM, Rich MW, Masoudi FA, Spertus JA, Krumholz HM, Alexander KP. Physical function and independence 1 year after myocardial infarction: Observations from the Translational Research Investigating Underlying disparities in recovery from acute Myocardial infarction: Patients’ Health status registry. Am Heart J, 2012, 163:(5):790-796.

26. Arnold SV, Smolderen KG, Buchanan DM, Li Y, Spertus JA. Perceived Stress in Myocardial Infarction: Long-Term Mortality and Health Status Outcomes. J Am Coll Cardiol, 2012, 60(18):1756-1763.

27. Cresci S, Dorn GW, 2nd, Jones PG, Beitelshees AL, Li AY, Lenzini PA, Province MA, Spertus JA, Lanfear DE. Adrenergic-pathway gene variants influence Beta-blocker-related outcomes after acute coronary syndrome in a race-specific manner. J Am Coll Cardiol, 2012, 60:(10):898-907.

28. Martin SS, Gosch K, Kulkarni KR, Spertus JA, Mathews R, Ho PM, Maddox TM, Newby LK, Alexander KP, Wang TY. Modifiable factors associated with failure to attain low-density lipoprotein cholesterol goal at 6 months after acute myocardial infarction. Am Heart J, 2013, 165:(1):26-33 e23.

29. Harris WS, Kennedy KF, O’Keefe JH, Jr., Spertus JA. Red blood cell fatty acid levels improve GRACE score prediction of 2-yr mortality in patients with myocardial infarction. Int J Cardiol. 2013, 168:(1)53-9.

30. Amin AP, Bachuwar A, Reid KJ, Chhatriwalla AK, Salisbury AC, Yeh RW, Kosiborod M, Wang TY, Alexander KP, Cohen DJ, Spertus JA, Bach RG. Nuisance Bleeding With Prolonged Dual Antiplatelet Therapy After Acute Myocardial Infarction and its Impact on Health Status. J Am Coll Cardiol, 2013, 61:(21)2130-8.

31. Arnold SV, Lipska KJ, Li Y, Goyal A, Maddox TM, McGuire DK, Spertus JA, Kosiborod M. The Reliability and Prognosis of In-hospital Diagnosis of Metabolic Syndrome in the Setting of Acute Myocardial Infarction. J Am Coll Cardiol, 2013, 62:(8)704-8.

32. Karrowni W, Li Y, Jones PG, Cresci S, Abdallah MS, Lanfear DE, Maddox TM, McGuire DK, Spertus JA, Horwitz PA. Insulin Resistance Is Associated With Significant Clinical Atherosclerosis in Nondiabetic Patients With Acute Myocardial Infarction. Arterioscler Thromb Vasc Biol, 2013, 33:(9)2245-2251.

33. Miller AL, Gosch K, Daugherty SL, Rathore S, Peterson PN, Peterson ED, Ho PM, Chan PS, Lanfear DE, Spertus JA, Wang TY. Failure to reassess ejection fraction after acute myocardial infarction in potential implantable cardioverter/defibrillator candidates: Insights from the Translational Research Investigating Underlying disparities in acute Myocardial infarction Patients’ Health Status (TRIUMPH) registry. Am Heart J, 2013, 166:(4)737-743.

34. Abramsohn EM, Decker C, Garavalia B, Garavalia L, Gosch K, Krumholz HM, Spertus JA, Lindau ST. “I’m Not Just a Heart, I’m a Whole Person Here”: A Qualitative Study to Improve Sexual Outcomes in Women With Myocardial Infarction. J Am Heart Assoc, 2013, 2:(4)e000199.

35. Krumholz HM, Barreto-Filho JA, Jones PG, Li Y, Spertus JA. Decision-making preferences among patients with an acute myocardial infarction. JAMA Intern Med, 2013, 173:(13)1252-7.

36. Parashar S, Kella D, Reid KJ, Spertus JA, Tang F, Langberg J, Vaccarino V, Kontos MC, Lopes RD, Lloyd MS. New-Onset Atrial Fibrillation After Acute Myocardial Infarction and Its Relation to Admission Biomarkers (from the TRIUMPH Registry). Am J Cardiol, 2013, 112:(9)1390-5.

37. Arnold SV, Spertus JA, Masoudi FA, Daugherty SL, Maddox TM, Li Y, Dodson JA, Chan PS. Beyond medication prescription as performance measures: optimal secondary prevention medication dosing after acute myocardial infarction. J Am Coll Cardiol. 2013;62(19):1791-1801.

38. Al Badarin FJ, Spertus JA, Gosch KL, Buchanan DM, Chan PS. Initiation of statin therapy after acute myocardial infarction is not associated with worsening depressive symptoms: Insights from the Prospective Registry Evaluating Outcomes After Myocardial Infarctions: Events and Recovery (PREMIER) and Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients’ Health Status (TRIUMPH) registries. Am Heart J, 2013, 166:(5)879-86.

39. Shore S, Maddox TM, Tang F, Jones PG, Lanfear DE, Ho PM. Gap between clinical guidelines and practice: the case of aldosterone-antagonists in patients with myocardial infarction. Int J Cardiol. 2014;172(1):e151-153.

40. Chan PS, Jones PG, Arnold SA, Spertus JA. Development and validation of a short version of the Seattle angina questionnaire. Circ Cardiovasc Qual Outcomes, 2014;7(5):640-647.

41. Arnold SV, Kosiborod M, Tang F, Zhao Z, Maddox TM, McCollam PL, Birt J, Spertus JA. Patterns of Statin Initiation, Intensification, and Maximization Among Patients Hospitalized with an Acute Myocardial Infarction. Circulation, 2014, 129:(12)1303-1309.

42. Arnold SV, Masoudi FA, Rumsfeld JS, Li Y, Jones PG, Spertus JA. Derivation and validation of a risk standardization model for benchmarking hospital performance for health-related quality of life outcomes after acute myocardial infarction. Circulation, 2014, 129:(3)313-20.

43. Arnold SV, Kosiborod M, Tang F, Zhao Z, McCollam PL, Birt J, Spertus JA. Changes in Low-Density Lipoprotein Levels after Discharge for Acute Myocardial Infarction in a Real-World Patient Population. Am J Epidemiol, 2014, 179(11):1293-1300.

44. Abdallah MS, Kosiborod M, Tang F, Karrowni WY, Maddox TM, McGuire DK, Spertus JA, Arnold SV. Patterns and Predictors of Intensive Statin Therapy Among Patients With Diabetes Mellitus After Acute Myocardial Infarction. Am J Cardiol, 2014, 113:(8) 1267-1272.
45. Arnold SV, Spertus JA, Lipska KJ, Lanfear DE, Tang F, Grodzinsky A, McGuire DK, Gore MO, Goyal A, Maddox TM, Kosiborod M. Type of beta-blocker use among patients with versus without diabetes after myocardial infarction. Am Heart J. 2014;168(3):273-279 e271.

46. Cresci S, Depta JP, Lenzini PA, Li AY, Lanfear DE, Province MA, Spertus JA, Bach RG. Cytochrome p450 gene variants, race, and mortality among clopidogrel-treated patients after acute myocardial infarction. Circ Cardiovasc Genet. 2014;7(3):277-286.

47. Chen LS, Bach RG, Lenzini PA, Spertus JA, Bierut LJ, Cresci S. CHRNA5 variant predicts smoking cessation in patients with acute myocardial infarction. Nicotine Tob Res, 2014,Sep;16(9):1224-1231.

48. Arnold SV, Lipska KJ, Inzucchi SE, Li Y, Jones PG, McGuire DK, Goyal A, Stolker JM, Lind M, Spertus JA, Kosiborod M. The reliability of in-hospital diagnoses of diabetes mellitus in the setting of an acute myocardial infarction. BMJ Open Diabetes Res Care, 2014;2(1):e000046.

49. Arnold SV, Lipska KJ, Li Y, McGuire DK, Goyal A, Spertus JA, Kosiborod M. Prevalence of glucose abnormalities among patients presenting with an acute myocardial infarction. Am Heart J. 2014;168(4):466-470 e461.

50. Vigen R, Spertus JA, Maddox TM, Ho PM, Jones PG, Arnold SV, Masoudi FA, Bradley SM. Hospital-Level Variation in Angina and Mortality at 1 Year After Myocardial Infarction: Insights From the Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients’ Health Status (TRIUMPH) Registry. Circ Cardiovasc Qual Outcomes, 2014;7(6):851-856.

51. Martin SS, Khokhar AA, May HT, Kulkarni KR, Blaha MJ, Joshi PH, Toth PP, Muhlestein JB, Anderson JL, Knight S, Li Y, Spertus JA, Jones SR. HDL cholesterol subclasses, myocardial infarction, and mortality in secondary prevention: the lipoprotein investigators collaborative. Eur Heart J, 2015,;36(1):22-30.

52. Depta JP, Lenzini PA, Lanfear DE, Wang TY, Spertus JA, Bach RG, Cresci S. Clinical outcomes associated with proton pump inhibitor use among clopidogrel-treated patients within CYP2C19 genotype groups following acute myocardial infarction. Pharmacogenomics J, 2015;15(1):20-25.

53. Arnold SV, Spertus JA, Lipska KJ, Tang F, Goyal A, McGuire DK, Cresci S, Maddox TM, Kosiborod M. Association between diabetes mellitus and angina after acute myocardial infarction: analysis of the TRIUMPH prospective cohort study. Eur J Prev Cardiol, 2015, 22(6):779-787.

54. Arnold SV, Smolderen KG, Kennedy KF, Li Y, Shore S, Stolker JM, Wang TY, Jones PG, Zhao Z, Spertus JA. Risk factors for rehospitalization for acute coronary syndromes and unplanned revascularization following acute myocardial infarction. J Am Heart Assoc, 2015;4(2).

55. Arnold SV, Stolker JM, Lipska KJ, Jones PG, Spertus JA, McGuire DK, Inzucchi SE, Goyal A, Maddox TM, Lind M, Gumber D, Shore S, Kosiborod M. Recognition of incident diabetes mellitus during an acute myocardial infarction. Circ Cardiovasc Qual Outcomes, 2015, 8(3):260-267.

56. Shore S, Jones PG, Maddox TM, Bradley SM, Stolker JM, Arnold SV, Parashar S, Peterson P, Bhatt DL, Spertus J, Ho PM. Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction. Heart, 2015, 101(10):800-807.

57. Dodson J, Arnold SV, Gosch KL, Gill TM, Spertus J, Krumholz HM, Rich M, Chaudhry SI, Forman DE, Masoudi FA, Alexander KP. The Association of Slow Gait Speed with the Risk of Mortality or Hospital Readmission following Acute Myocardial Infarction: Insights from the TRIUMPH Registry. Am Heart J, 2015 (In Press).

58. Wetmore JB, Tang F, Sharma A, Jones PG, Spertus JA. The Association of Chronic Kidney Disease with the Use of Renin-Angiotensin System Inhibitors after Acute Myocardial Infarction. Am Heart J, 2015;170(4):735-743.

59. Buchanan DM, Arnold SV, Gosch KL, Jones PG, Longmore LS, Spertus JA, Cresci S. Association of Smoking Status With Angina and Health-Related Quality of Life After Acute Myocardial Infarction. Circ Cardiovasc Qual Outcomes, 2015, 8(5):493-500.

60. Swiger KJ, Martin SS, Tang F, Blaha MJ, Blumenthal RS, Alexander KP, Arnold SV, Spertus JA. Cognitive and Physical Function by Statin Exposure in Elderly Individuals Following Acute Myocardial Infarction. Clin Cardiol, 2015;38(8):455-461.

61. Chhatriwalla AK, Venkitachalam L, Kennedy KF, Stolker JM, Jones PG, Cohen DJ, Spertus JA. Relationship between stent type and quality of life after percutaneous coronary intervention for acute myocardial infarction. Am Heart J. 2015 170(4):796-804. PMID: 26386804.

62. Labos C, Martinez SC, Leo Wang RH, Lenzini PA, Pilote L, Bogaty P, Brophy JM, Engert JC, Cresci S, Thanassoulis G. Utility of a genetic risk score to predict recurrent cardiovascular events 1 year after an acute coronary syndrome: A pooled analysis of the RISCA, PRAXY, and TRIUMPH cohorts. Atherosclerosis, 2015;242(1):261-267.

Created: October 26, 2015 12:37
Last updated: October 30, 2015 09:18


Comments

There are no comments so far.

If you signup and login, you can post comments.